{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:26:20Z","timestamp":1760189180797},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jss.2011.03.067","type":"journal-article","created":{"date-parts":[[2011,4,22]],"date-time":"2011-04-22T22:53:53Z","timestamp":1303512833000},"page":"e43-e50","source":"Crossref","is-referenced-by-count":21,"title":["Combinatorial Therapy for Liver Metastatic Colon Cancer: Dendritic Cell Vaccine and Low-Dose Agonistic Anti-4-1BB Antibody Co-Stimulatory Signal"],"prefix":"10.1016","volume":"169","author":[{"given":"Hyunah","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Jin","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Man","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2011.03.067_bib1","unstructured":"Ministry of Health, Welfare and Family affairs, Korea. Annual Report of Cancer Incidence (2005) and Survival (1993\u20132005) in Korea, 2008."},{"key":"10.1016\/j.jss.2011.03.067_bib2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20012100","article-title":"Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells","volume":"195","author":"Schuler-Thurner","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jss.2011.03.067_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jss.2011.03.067_bib4","first-page":"3369","article-title":"Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells","volume":"8","author":"Holtl","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2011.03.067_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00262-003-0375-x","article-title":"Durable complete clinical responses in a phase I\/II trial using an autologous melanoma cell\/dendritic cell vaccine","volume":"52","author":"O\u2019Rourke","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jss.2011.03.067_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00262-002-0360-9","article-title":"A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer","volume":"52","author":"Iwashita","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jss.2011.03.067_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/14653240600735701","article-title":"Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma","volume":"8","author":"Guardino","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jss.2011.03.067_bib8","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/sj.leu.2403860","article-title":"Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia","volume":"19","author":"Hus","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.jss.2011.03.067_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clim.2007.07.014","article-title":"Phase I\/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma","volume":"125","author":"Kim","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jss.2011.03.067_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-065X.2008.00621.x","article-title":"The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer","volume":"222","author":"Lynch","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jss.2011.03.067_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1016-8478(23)10765-5","article-title":"Marked expansion of CD11c+CD8+ T-cells in melanoma-bearing mice induced by anti-4-1BB monoclonal antibody","volume":"24","author":"Ju","year":"2007","journal-title":"Mol Cells"},{"key":"10.1016\/j.jss.2011.03.067_bib12","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.4049\/jimmunol.174.12.7625","article-title":"Peptide-specific CD8 T regulatory cells use IFN-gamma to elaborate TGF-beta-based suppression","volume":"174","author":"Myers","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jss.2011.03.067_bib13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s00109-006-0072-2","article-title":"Dual immunoregulatory pathways of 4-1BB signaling","volume":"84","author":"Vinay","year":"2006","journal-title":"J Mol Med"},{"key":"10.1016\/j.jss.2011.03.067_bib14","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1073\/pnas.0837611100","article-title":"Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering","volume":"100","author":"Myers","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jss.2011.03.067_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.it.2005.06.003","article-title":"Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation","volume":"26","author":"Myers","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jss.2011.03.067_bib16","doi-asserted-by":"crossref","first-page":"8411","DOI":"10.1158\/0008-5472.CAN-04-0590","article-title":"Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines","volume":"64","author":"Ito","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2011.03.067_bib17","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.3748\/wjg.v13.i44.5822","article-title":"Immunotherapy and immunoescape in colorectal cancer","volume":"13","author":"Mazzolini","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jss.2011.03.067_bib18","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1158\/0008-5472.CAN-08-1365","article-title":"Combination therapy with cisplatin and anti-4-1BB: Synergistic anticancer effects and amelioration of cisplatin-induced nephrotoxicity","volume":"68","author":"Kim","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2011.03.067_bib19","doi-asserted-by":"crossref","first-page":"8891","DOI":"10.1158\/0008-5472.CAN-07-1056","article-title":"Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy","volume":"67","author":"Choi","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2011.03.067_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ijc.20093","article-title":"Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens","volume":"110","author":"Tirapu","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jss.2011.03.067_bib21","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1158\/0008-5472.CAN-05-2128","article-title":"Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer\u00a0immunity and reduces autoimmunity","volume":"66","author":"Kocak","year":"2006","journal-title":"Cancer Res"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480411003039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480411003039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T09:19:09Z","timestamp":1712395149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480411003039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022480411003039"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2011.03.067","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}